Calmoseptine Cream Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Calmoseptine is the best-performing calmoseptine cream brand in July 2026, moving 22,000 units across 3 ASINs for 56.4% of Top 10 volume. TUBBY TODD follows with 7,000 units (17.9%), ahead of Medline Remedy on 5,000 units (12.8%).

With 6 brands splitting the Top 10 and 87.2% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $10.44 to $35.99, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, one ASIN forced its way in: B0F9DR31M4 booked 7K units at $35.99. On the growth side, B01M3YQZZB leads positive momentum with ▲ 100.0% MoM growth on 200 units, with B01ALC01ZU close behind at ▲ 100.0% MoM on 100 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.